Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Indivior Pharmaceuticals, Inc.

NASDAQ: SUPN · Life Sciences · 7 alerts · CIK 1625297

Share price
$28.83Close, Nov 16
Market cap
$3.4B
Shares outstanding
118.04MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Indivior Pharmaceuticals, Inc. filings on SEC EDGAR ↗

4:28 PM ET 8-K
Deal Termination

Indivior Pharmaceuticals Deal Termination with Reckitt Benckiser Healthcare Limited

Indivior UK Limited and Reckitt Benckiser Healthcare (UK) Limited entered into a Deed of Variation and Termination to accelerate the end of their Copacker Supply Agreement for SUBOXONE and SUBUTEX tablets to January 15, 2027. Indivior has identified a new supplier and will pay RB fixed or capped costs related to the early termination, including asset disposal and redundancy costs. The company stated the financial impact of the termination and the new supplier agreement is not expected to be material.

Counterparty
Reckitt Benckiser Healthcare (UK) Limited
Term
through Jan 15, 2027

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.